Description

The Women's Health - Menopause project, launched on October 1, 2023, is an investigational study lasting 36 months and designed to explore the different phases of menopause. The objective is to delineate each phase and to observe biomarker fluctuations during the transitions from the perimenopause phase to post-menopause. In addition, the research seeks to examine changes in biomarkers and biometric data in response to different menopause treatments, including hormone therapies. BioTwin focuses on contributing information that may support the understanding of menopause within the scientific community, with the ultimate objective of developing future strategies adapted to individual profiles. We invite researchers and participants interested in this area of women's health to collaborate and to share their knowledge. Your contribution is invaluable in advancing this scientific investigation.

Eligibility

Women in the perimenopause period, menopause period, or post-menopause period.

Objective

Understand and improve outcomes for women's health - menopause.

Expected outcomes

  • Profile of all phases of menopause
  • Tracking of biomarkers during phase transitions.
  • Monitoring of the effects of different menopause treatments, such as hormone therapy.